Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;151(1-3):197-202.
doi: 10.1016/j.schres.2013.10.018. Epub 2013 Nov 5.

Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions

Glen P Davis  1 , Michael T Compton, Shuai Wang, Frances R Levin, Carlos Blanco
Affiliations

Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions

Glen P Davis et al. Schizophr Res. 2013 Dec.

Abstract

Background: Studies to date showing an association between cannabis use and schizophrenia-spectrum disorders are of relatively small sample sizes with limitations in generalizability. The present study addresses this gap by examining the relationship between cannabis use and psychotic-like symptoms in a large representative community sample.

Method: Data were derived from the 2004-2005 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC, Wave 2), a large, nationally representative sample of 34,653 adults from the United States population. We evaluated the association between lifetime cannabis use, psychosis, and schizotypal personality features.

Results: The prevalence of psychosis and schizotypal personality disorder increased significantly with greater cannabis use in a dose-dependent manner. The associations between cannabis use and psychosis were 1.27 (95% CI 1.03-1.57) for lifetime cannabis use, 1.79 (95% CI 1.35-2.38) for lifetime cannabis abuse, and 3.69 (95% CI 2.49-5.47) for lifetime cannabis dependence. There was a similar dose-response relationship between the extent of cannabis use and schizotypal personality disorder (OR=2.02 for lifetime cannabis use, 95% CI 1.69-2.42; OR=2.83 for lifetime cannabis abuse, 95% CI 2.33-2.43; OR=7.32 for lifetime cannabis dependence, 95% CI 5.51-9.72). Likelihood of individual schizotypal features increased significantly with increased extent of cannabis use in a dose-dependent manner.

Conclusion: This is the first population-based study to examine the association between lifetime cannabis use, psychosis, and schizotypal personality traits. These results add to evidence that cannabis use may be a risk factor for psychosis liability.

Keywords: Cannabis; Epidemiology; NESARC; Psychosis; Schizotypal.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Relationship between cannabis use, abuse, and dependence and three of nine features of schizotypal personality disorder in NESARC Wave 2 (n = 34,653). (a) Suspicious or paranoid ideation; (b) Inappropriate or constricted affect; (c) Behavior or appearance that is odd, eccentric, or peculiar.
See this image and copyright information in PMC

References

    1. Agosti V, Nunes E, Levin F. Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse. 2002;28(4):643–652. - PubMed
    1. Ahmed AO, Green A, Goodrum NM, Doane NJ, Birgenheir D, Buckley PF. Does a latent class underlie schizotypal personality disorder? Implications for schizophrenia. J Abnorm Psychol. 2013;122(2):475–491. - PubMed
    1. Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol. 1999;58(4):315–348. - PubMed
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: 1994.
    1. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987;2(8574):1483–1486. - PubMed

Publication types